Therefore, we speculate that the METTL14/CCL5/Tregs axis might be a potential pivotal regulated pathway of tumor immunity and progression in ccRCC (Figure 7H), a subject worthy of further in-depth study. The gene discussed is CCL5; the disease is nonpapillary renal cell carcinoma.